Literature DB >> 33597629

Oral and ocular late effects in head and neck cancer patients treated with radiotherapy.

Kristine Løken Westgaard1,2, Håvard Hynne1, Bente Brokstad Herlofson1,2, Janicke Liaaen Jensen3, Cecilie Delphin Amdal4, Alix Young5, Preet Bano Singh1,2, Xiangjun Chen1, Morten Rykke5, Lene Hystad Hove5, Lara A Aqrawi1, Tor P Utheim6,7.   

Abstract

A broader understanding of oral and ocular late effects in head and neck cancer (HNC) patients who underwent intensity-modulated radiotherapy (IMRT) may provide valuable information in follow-up and improve quality of life. Twenty-nine HNC patients treated at least 6 months earlier and 30 age-matched controls were recruited. After completing several questionnaires: Oral Health Impact Profile-14 (OHIP-14), Shortened Xerostomia Inventory (SXI), Ocular Surface Disease Index (OSDI) and McMonnies Dry Eye questionnaire (MDEQ), participants underwent oral and ocular examinations. Oral examination included clinical oral dryness score (CODS) and secretion rates of unstimulated and stimulated saliva (UWS, SWS). Ocular examination included tear film break-up time, Schirmer test and ocular surface staining. The patients had more problems related to dry mouth than controls based on CODS and SXI, and more complaints of dry eye disease based on OSDI and MDEQ. UWS and SWS rates and oral health related quality of life were significantly lower in the patient group. Subjective oral dryness (SXI) correlated significantly with subjective ocular dryness (OSDI and MDEQ). Our study demonstrates that HNC patients treated with IMRT experience late effects in terms of xerostomia and ocular dryness underlining the importance of interdisciplinary approach in the evaluation and follow-up of HNC patients.

Entities:  

Mesh:

Year:  2021        PMID: 33597629      PMCID: PMC7889862          DOI: 10.1038/s41598-021-83635-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  39 in total

Review 1.  Radiotherapy-induced ocular surface disease.

Authors:  Stefano Barabino; Anita Raghavan; Jay Loeffler; Reza Dana
Journal:  Cornea       Date:  2005-11       Impact factor: 2.651

Review 2.  Ophthalmic and adnexal complications of radiotherapy.

Authors:  Shane R Durkin; Daniel Roos; Braden Higgs; Robert J Casson; Dinesh Selva
Journal:  Acta Ophthalmol Scand       Date:  2007-05

Review 3.  TFOS DEWS II Diagnostic Methodology report.

Authors:  James S Wolffsohn; Reiko Arita; Robin Chalmers; Ali Djalilian; Murat Dogru; Kathy Dumbleton; Preeya K Gupta; Paul Karpecki; Sihem Lazreg; Heiko Pult; Benjamin D Sullivan; Alan Tomlinson; Louis Tong; Edoardo Villani; Kyung Chul Yoon; Lyndon Jones; Jennifer P Craig
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

4.  Taste disorders following cancer treatment: report of a case series.

Authors:  Joel B Epstein; Safira Marques de Andrade E Silva; Geena L Epstein; Jorge Henrique Santos Leal; Andrei Barasch; Gregory Smutzer
Journal:  Support Care Cancer       Date:  2019-03-29       Impact factor: 3.603

5.  Responses to a dry eye questionnaire from a normal population.

Authors:  C W McMonnies; A Ho
Journal:  J Am Optom Assoc       Date:  1987-07

6.  Quality of life and oral function in patients treated with radiation therapy for head and neck cancer.

Authors:  J B Epstein; M Robertson; S Emerton; N Phillips; P Stevenson-Moore
Journal:  Head Neck       Date:  2001-05       Impact factor: 3.147

7.  Oral microflora in subjects with reduced salivary secretion.

Authors:  A Almståhl; M Wikström
Journal:  J Dent Res       Date:  1999-08       Impact factor: 6.116

Review 8.  Advances in Supportive Care for Late Effects of Head and Neck Cancer.

Authors:  Barbara A Murphy; Jie Deng
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

Review 9.  A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life.

Authors:  S B Jensen; A M L Pedersen; A Vissink; E Andersen; C G Brown; A N Davies; J Dutilh; J S Fulton; L Jankovic; N N F Lopes; A L S Mello; L V Muniz; C A Murdoch-Kinch; R G Nair; J J Napeñas; A Nogueira-Rodrigues; D Saunders; B Stirling; I von Bültzingslöwen; D S Weikel; L S Elting; F K L Spijkervet; M T Brennan
Journal:  Support Care Cancer       Date:  2010-03-17       Impact factor: 3.603

Review 10.  Xerostomia induced by radiotherapy: an overview of the physiopathology, clinical evidence, and management of the oral damage.

Authors:  Roberto Pinna; Guglielmo Campus; Enzo Cumbo; Ida Mura; Egle Milia
Journal:  Ther Clin Risk Manag       Date:  2015-02-04       Impact factor: 2.423

View more
  4 in total

1.  Saliva Metabolomics in Dry Mouth Patients with Head and Neck Cancer or Sjögren's Syndrome.

Authors:  Håvard Hynne; Elise Mørk Sandås; Katja Benedikte Prestø Elgstøen; Helge Rootwelt; Tor P Utheim; Hilde Kanli Galtung; Janicke Liaaen Jensen
Journal:  Cells       Date:  2022-01-19       Impact factor: 6.600

2.  Alterations in meibomian glands in patients treated with intensity-modulated radiotherapy for head and neck cancer.

Authors:  Xiangjun Chen; Reza A Badian; Håvard Hynne; Cecilie Delphin Amdal; Bente Brokstad Herlofson; Øygunn Aass Utheim; Kristine Løken Westgaard; Fredrik Fineide; Janicke Liaaen Jensen; Tor Paaske Utheim
Journal:  Sci Rep       Date:  2021-11-17       Impact factor: 4.379

Review 3.  Is There an Interplay between Oral Microbiome, Head and Neck Carcinoma and Radiation-Induced Oral Mucositis?

Authors:  Patryk Gugnacki; Ewa Sierko
Journal:  Cancers (Basel)       Date:  2021-11-24       Impact factor: 6.639

4.  Proteomic Profiling of Saliva and Tears in Radiated Head and Neck Cancer Patients as Compared to Primary Sjögren's Syndrome Patients.

Authors:  Håvard Hynne; Lara A Aqrawi; Janicke Liaaen Jensen; Bernd Thiede; Øyvind Palm; Cecilie Delphin Amdal; Kristine Løken Westgaard; Bente Brokstad Herlofson; Tor P Utheim; Hilde Kanli Galtung
Journal:  Int J Mol Sci       Date:  2022-03-28       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.